225 related articles for article (PubMed ID: 11471362)
1. [Prevention in cardiovascular pathology].
Chamontin B; Amar J
Therapie; 2001; 56(2):119-24. PubMed ID: 11471362
[TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension management in general practice in France according to global risk factors].
Amar J; Vaur L; Perret M; Bailleau C; Etienne S; Chamontin B
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):843-5. PubMed ID: 11575215
[TBL] [Abstract][Full Text] [Related]
3. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
[TBL] [Abstract][Full Text] [Related]
4. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
5. [Influence of cardiovascular risk factors on prescribing of antihypertensives].
Vaur L; Amar J; Perret M; Bailleau C; Etienne S; Chamontin B
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):846-50. PubMed ID: 11575216
[TBL] [Abstract][Full Text] [Related]
6. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
Hanon O; Hoguin JC; Girerd X
Arch Mal Coeur Vaiss; 2003; 96(7-8):744-7. PubMed ID: 12945215
[TBL] [Abstract][Full Text] [Related]
7. [Hypertension. New French recommendations].
Milon H; Mestre C; Lantelme P
Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1479-86. PubMed ID: 11190299
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
[TBL] [Abstract][Full Text] [Related]
9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular prevention: not necessary under the age of 40].
Walma EP
Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
[TBL] [Abstract][Full Text] [Related]
13. Diuretics for cardiovascular prevention in the elderly.
Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
[TBL] [Abstract][Full Text] [Related]
14. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
Rabinowitz I; Tamir A
Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification for the prevention of cardiovascular complications of hypertension.
Girerd X; Giral P
Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations of the French National Health Authority for management of high blood pressure in clinical practice].
Bordier L; Baigts F; Mayaudon H; Dupuy O; Le Berre JP; Garcia C; Bauduceau B;
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):605-8. PubMed ID: 17928760
[TBL] [Abstract][Full Text] [Related]
17. [Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Evaluation and stratification of cardiovascular risk based on the 2000 ANAES recommendations in a population of hypertensive patients].
Mounier-Vehier C; Amah G; Covillard J; Jaboureck O; Phan TM
Arch Mal Coeur Vaiss; 2002; 95(7-8):667-72. PubMed ID: 12365077
[TBL] [Abstract][Full Text] [Related]
18. [The best of epidemiology and cardiovascular prevention in 2006].
Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations in cardiovascular prevention.
Follath F
Fundam Clin Pharmacol; 2009 Dec; 23(6):669-73. PubMed ID: 19500153
[TBL] [Abstract][Full Text] [Related]
20. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
